Literature DB >> 24572992

Interleukin-6 in inflammatory and malignant diseases of the pancreas.

Marina Lesina1, Sonja Maria Wörmann1, Patrick Neuhöfer1, Liang Song1, Hana Algül2.   

Abstract

Interleukin-6 is an important pro-inflammatory cytokine strongly linked to the most burdened exocrine pancreatic diseases including acute pancreatitis, chronic pancreatitis and pancreatic cancer. However, its role in all these diseases is versatile and not completely defined. Several studies provided accumulating evidence that IL-6 is mainly involved in the JAK/STAT pathway activation promoting acute and chronic pancreatitis disease aggravation as well as pancreatic cancer initiation and progression. This review will focus on recent studies illustrating the role of IL-6 in acute and chronic pancreatitis and pancreatic oncogenesis. Further, a short overview of indicated disease pathologies will be given and the impact of IL-6 in JAK/STAT pathway, persistent STAT3 activation and cancer immunotherapy will be discussed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Chronic pancreatitis; IL-6 signaling; IL-6 trans-signaling; Pancreatic cancer; STAT3

Mesh:

Substances:

Year:  2014        PMID: 24572992     DOI: 10.1016/j.smim.2014.01.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  48 in total

1.  Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics.

Authors:  Carolyn C Arpin; Stephen Mac; Yanlin Jiang; Huiwen Cheng; Michelle Grimard; Brent D G Page; Malgorzata M Kamocka; Sina Haftchenary; Han Su; Daniel P Ball; David A Rosa; Ping-Shan Lai; Rodolfo F Gómez-Biagi; Ahmed M Ali; Rahul Rana; Helmut Hanenberg; Kagan Kerman; Kyle C McElyea; George E Sandusky; Patrick T Gunning; Melissa L Fishel
Journal:  Mol Cancer Ther       Date:  2016-02-12       Impact factor: 6.261

2.  IL-6 Trans-Signaling Drives Murine Crescentic GN.

Authors:  Gerald S Braun; Yoshikuni Nagayama; Yuichi Maruta; Felix Heymann; Claudia R van Roeyen; Barbara M Klinkhammer; Peter Boor; Luigi Villa; David J Salant; Ute Raffetseder; Stefan Rose-John; Tammo Ostendorf; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2015-06-03       Impact factor: 10.121

Review 3.  Early phase of acute pancreatitis: Assessment and management.

Authors:  Veit Phillip; Jörg M Steiner; Hana Algül
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.

Authors:  Xiaojuan Wu; Yang Cao; Hui Xiao; Chenglong Li; Jiayuh Lin
Journal:  Mol Cancer Ther       Date:  2016-08-17       Impact factor: 6.261

5.  Apigenin inhibits pancreatic stellate cell activity in pancreatitis.

Authors:  Amy A Mrazek; Laura J Porro; Vandanajay Bhatia; Miriam Falzon; Heidi Spratt; Jia Zhou; Celia Chao; Mark R Hellmich
Journal:  J Surg Res       Date:  2015-02-19       Impact factor: 2.192

6.  Chronic Pancreatitis Associated Acute Respiratory Failure.

Authors:  Murli Manohar; Alok K Verma; Sathisha Upparahalli Venkateshaiah; Nathan L Sanders; Anil Mishra
Journal:  MOJ Immunol       Date:  2017-02-08

7.  Level of serum soluble Tim-3 expression in early-phase acute pancreatitis.

Authors:  Min Lin; Jin Huang; Jian Huang; Sheng-Lan Liu; Wei-Chang Chen
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

8.  Wnt5a/FZD5/CaMKII signaling pathway mediates the effect of BML-111 on inflammatory reactions in sepsis.

Authors:  Muhu Chen; Wu Zhong; Yingchun Hu; Jitao Liu; Xianfu Cai
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.

Authors:  Jelena Todoric; Laura Antonucci; Giuseppe Di Caro; Ning Li; Xuefeng Wu; Nikki K Lytle; Debanjan Dhar; Sourav Banerjee; Johan B Fagman; Cecille D Browne; Atsushi Umemura; Mark A Valasek; Hannes Kessler; David Tarin; Michael Goggins; Tannishtha Reya; Maria Diaz-Meco; Jorge Moscat; Michael Karin
Journal:  Cancer Cell       Date:  2017-11-16       Impact factor: 31.743

10.  Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.

Authors:  Ioannis Pozios; Thomas Knösel; Yue Zhao; Gerald Assmann; Iraklis Pozios; Mario H Müller; Christiane J Bruns; Martin E Kreis; Hendrik Seeliger
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-25       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.